199 Bay St, Suite 5300, Commerce Court West, Toronto, ON
Year called to bar: 2007 (QC); 2019 (ON)
Kim Le is Co-Head of the Mergers & Acquisitions and Private Equity Groups in the Toronto office. Her practice focuses on corporate and commercial law, including public and private mergers and acquisitions. Kim has extensive experience working with private equity funds, private equity portfolio companies, and multinational corporations, as well as advising on all aspects of cross-border private equity. Kim also works on matters involving venture capital investments, joint ventures and partnerships, complex shareholder agreements, and insolvency and restructuring. She represents and acts as a trusted advisor on general corporate and commercial matters for clients across the technology, food and beverage, mining, and engineering industries. Kim’s expertise is recognized by national and international directories, and she was awarded as a Leading Lawyer Under 40 by the Lexpert Rising Stars Awards.
Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, completed its acquisition of Omega Laboratories Limited, a market leading specialty pharmaceutical company based in Montreal, for approximately US$85.3 million (C$95 million) in cash. The combination of Sagent and Omega creates a premier generic injectable company with a robust product portfolio, deep development pipeline and strong global presence.